Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck

Publication Date: April 23, 2020
Last Updated: March 14, 2022


Recommendations 

Preoperative Evaluation 

Patients undergoing evaluation for a neck mass suspicious for squamous cell carcinoma should undergo a thorough history and physical examination including fiberoptic laryngoscopy that may be complemented with advanced visualization techniques such as narrow band imaging (NBI) to facilitate identification of the anatomic location of the primary tumor and to inform potential therapeutic management options. ( IC , B , L , M )
618
Fine-Needle aspiration or core biopsy of a clinically suspicious neck mass should be performed. ( EB , B , I , S )
618
High-risk human papillomavirus (HR-HPV) testing should be done routinely on level II and III SCCUP nodes. Epstein-Barr virus (EBV) testing should be considered on HPV-negative metastases. ( EB , B , I , M )

Note: HR-HPV testing may be done non-routinely for squamous cell carcinoma metastases at other nodal levels when clinical suspicion is high.

618
Contrast enhanced computed tomography (CECT) of the neck should be the initial test for work-up of metastatic cervical lymphadenopathy. ( EB , B , I , S )
618
If a primary is not evident on clinical examination and CECT, positron emission tomography (PET)-CT should be the next diagnostic step. ( EB , B , I , S )
618

Overview

Title

Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck

Authoring Organization

American Society of Clinical Oncology